Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00139061
Status:
COMPLETED
Last Update Posted:
2007-10-31
First Post:
2005-08-26
Brief Title:
Assess HDL-C Increase And Non-HDL Lowering Effect Of TorcetrapibAtorvastatin Vs Fenofibrate
Sponsor:
Pfizer
Organization:
Pfizer
Study Overview
Official Title:
Phase 3 Multi-Center Double-Blind Randomized Parallel Group Forced Titration Study Of The Efficacy Safety And Tolerability Of TorcetrapibAtorvastatin Compared To Fenofibrate In Subjects With Fredrickson Type IIB Dyslipidemia Mixed Hyperlipidemia
Status:
COMPLETED
Status Verified Date:
2006-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The Torcetrapib project was terminated on December 2 2006 due to safety findings
To assess the HDL-C increase and non-HDL lowering effect of torcetrapibatorvastatin vs fenofibrate
To assess the HDL-C increase and non-HDL lowering effect of torcetrapibatorvastatin vs fenofibrate
Detailed Description:
For additional information please call 1-800-718-1021
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None